Early origin of adult renal disease

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 23, Issue SUPPL. 3, 2010, Pages 84-86

  Maringhini, Silvio ^a   Corrado, Ciro ^a   Maringhini, Guido ^a   Cusumano, Rosa ^a   Azzolina, Vitalba ^a   Leone, Francesco ^a  

^a ARNAS Civico   (Italy)

Author keywords

Fetal programming; prevention; renal disease

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CHILDHOOD DISEASE; CHRONIC KIDNEY DISEASE; CONGENITAL DISORDER; DNA METHYLATION; DNA SEQUENCE; EARLY CHILDHOOD INTERVENTION; ENVIRONMENTAL FACTOR; EPIGENETICS; FETUS DEVELOPMENT; GENE EXPRESSION; GENETIC PREDISPOSITION; HEALTH PROMOTION; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; LOW BIRTH WEIGHT; MATERNAL NUTRITION; METABOLIC SYNDROME X; NEPHRON; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ONSET AGE; PERINATAL CARE; PLACENTA CIRCULATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; URINARY TRACT DISEASE; ADULT; DISEASE PREDISPOSITION; FEMALE; GENETICS; NEWBORN; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; PRENATAL EXPOSURE; UROGENITAL TRACT MALFORMATION;

ADULT; AGE OF ONSET; DISEASE SUSCEPTIBILITY; FEMALE; FETAL DEVELOPMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; KIDNEY DISEASES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; UROGENITAL ABNORMALITIES;

EID: 77957960542     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2010.510245     Document Type: Review

References (25)

1. Zoccali C, Cambareri F. Chronic kidney disease epidemics - a gap in effectiveness: the distance between potential and actual treatment benefits. J Nephrol 2006;19:131-134.
2. Simeoni U, Boubred F, Buffat C, Vaiman D. The developing kidney and the fetal origins of adult cardiovascular disease. In: Oh W, Guignard JP, Baumgart S, editors. Neonatology questions and controversies. Nephrology and fluid/electrolyte physiology. Philadelphia: Saunders Elsevier; 2008. pp 97-106.
3. Maringhini S. Prevention in pediatric age of nephropathies in adults. Minerva Pediatr 2007;59:435-436.
4. Barker DJP. Developmental origins of adult health and disease. J Epidemiol Community Health 2004;58:114-115.
5. Puddu M, Fanos V, Podda F, Zaffanello M. The kidney from prenatal to adult life: Perinatal programming and reduction of number of nephrons during development. Am J Nephrol 2009;30:162-170.
6. Dressler GR. Epigenetics, development, and the kidney. J Am Soc Nephrol 2008;19:2060-2067.
7. Mohn A, Chiavaroli V, Cerruto M, Blasetti A, Giannini C, Bucciarelli T, Chiarelli F. Increased oxidative stress in prepubertal children born small for gestational age. J Clin Endocrinol Metab 2007;92:1372-1378.
8. Nilsson PM, Lurbe E, Laurent S. The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome. J Hypertens 2008;26:1049-1057.
9. Liew G, Wang JJ, Duncan BB, Klein R, Sharrett AR, Brancati F, Yeh HC, Mitchell P, Wong TY. Low birthweight is associated with narrower arterioles in adults. Hypertension 2008;51:933-938.
10. Tilling K, Smith GD, Chambless L, Rose K, Stevens J, Lawlor D, Szklo M. The relation between birth weight and intima-media thickness in middle-aged adults. Epidemiology 2004;15:557-564.
11. Celsi G, Kistner A, Aizman R, Eklö f AC, Ceccatelli S, de Santiago A, Jacobson SH. Prenatal dexamethasone causes oligonephronia, sodium retention, and higher blood pressure in the offspring. Pediatr Res 1998;44:317-322.
12. Hinchliffe AS, Lynch MR, Sargent PH, Howard CV, Van Velzen D. The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol 1992;99:296-301.
13. Fanos V, Puddu M, Reali A, Atzei A, Zaffanello M. Perinatal nutrient restriction reduces nephron endowment increasing renal morbidity in adulthood: a review. Early Hum Dev 2010;86:S37-S42.
14. Brenner BM, Chertow GM. Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 1994;23:171-175.
15. Huxley RR, Shiell AW, Law CM. The role of size at birth and postnatal catch-up growth in determining systolic blood pressure: a systematic review of the literature. J Hypertens 2000;18:815-831.
16. Merlet-Bénichou C, Gilbert T, Muffat-Joly M, Lelièvre- Pégorier M, Leroy B. Intrauterine growth retardation leads to a permanent nephron deficit in the rat. Pediatr Nephrol 1994;8:175-180.
17. Nwagwu MO, Cook A, Langley-Evans SC. Evidence of progressive deterioration of renal function in rats exposed to a maternal lowprotein diet in utero. Br J Nutr 2000;83: 79-85.
18. Pangala V, Bhat PV, Manolescu DC. Role of vitamin A in determining nephron mass and possible relationship to hypertension. J Nutr 2008;138:1407-1410.
19. Stewart CP, Christian P, Schulze KJ, Leclerq SC, West KP Jr, Khatry SK. Antenatal micronutrient supplementation reduces metabolic syndrome in 6- to 8-year-old children in rural Nepal. J Nutr 2009;139:1575-1581.
20. Cottrell EC, Seckl JR. Prenatal stress, glucocorticoids and the programming of adult disease. Front Behav Neurosci 2009; 3:19.
21. Grigore D, Ojeda NB, Alexander BT. Sex differences in the fetal rogramming of hypertension. Gend Med 2008;5 (Suppl A):S121-S132.
22. Neild GH. What do we know about chronic renal failure in young adults? II. Adult outcome of pediatric renal disease. Pediatr Nephrol 2009;24:1921-1928.
23. Fanos V, Cuzzolin L, Atzei A, Testa M. Antibiotics and antifungals in neonatal intensive care units: a review. J Chemother 2007;19:5-20.
24. Antonucci R, Fanos V. NSAIDs, prostaglandins and the neonatal kidney. J Matern Fetal Neonatal Med 2009;22 (Suppl 3):23-26.
25. Baum M. Role of the kidney in the prenatal and early postnatal programming of hypertension. Am J Physiol Renal Physiol 2010;298:F235-F247.